Searched query = "Muscular dystrophy", "Dystrophinopathies", "Myotilinopathy", "Laminopathy", "Caveolinopathy", "LGMD1C", "Desminopathy", "Sarcoglycanopathy", "α-dystroglycanopathy", "FCMD", "Walker-Warburg syndrome", "Muscle-eye-brain disease", "Myotonic dystrophy", "Integrin α7 deficient CMD", "Rigid spine syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|01/12/2008||11/12/2008||Effects of cardioprotective therapy, carvedilol vs ramipril, in patients affected by Duchenne and Becker muscular dystrophy. Clinical significance and prognostic value of Cardiac Magnetic Resonance study. - ND||Effects of cardioprotective therapy, carvedilol vs ramipril, in patients affected by Duchenne and Becker muscular dystrophy. Clinical significance and prognostic value of Cardiac Magnetic Resonance study. - ND||Duchenne and Becher muscular dystrophy |
MedDRA version: 9.1;Level: LLT;Classification code 10013801;Term: Duchenne muscular dystrophy
|Trade Name: DILATREND|
INN or Proposed INN: Carvedilol
Trade Name: TRIATEC
INN or Proposed INN: Ramipril
|POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI||NULL||Not Recruiting||Female: no|
|December 2008||8/1/2009||Ramipril Versus Carvedilol in Duchenne and Becker Patients||Effects of Cardioprotective Therapy, Carvedilol vs Ramipril, in Patients Affected by Duchenne and Becker Muscular Dystrophy. Clinical Significance and Prognostic Value of Cardiac Magnetic Resonance Study.||Duchenne Muscular Dystrophy;Becker Muscular Dystrophy||Drug: carvedilol;Drug: ramipril||Catholic University, Italy||NULL||Recruiting||2 Years||45 Years||Male||194||Phase 4||Italy|
|December 2007||22/1/2008||The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy||Carvedilol for the Prevention of Minor Cardiac Damage and Cardiac Function in Duchenne Muscular Dystrophy||Duchenne Muscular Dystrophy;Cardiomyopathies||Drug: Carvedilol||Suzuka Hospital||Nagoya University||Recruiting||8 Years||45 Years||Male||60||Phase 4||Japan|
|13/07/2006||Effect of carvedilol on left ventricular systolic and diastolic function and the neurohormonal axis in patients with Duchenne muscular dystrophy and left ventricular dysfunction.||Effect of carvedilol on left ventricular systolic and diastolic function and the neurohormonal axis in patients with Duchenne muscular dystrophy and left ventricular dysfunction.||Duchenne muscular dystrophy is an X-linked inherited disorder which primarily affects skeletal muscle through a mutation in dystrophin which maps to the long arm of the X chromosome (Xp21). Patients with skeletal myopathy such as DMD eventually progress to develop dilated cardiomyopathy as dystrophin is expressed in all forms of muscle including cardiac and smooth muscle. Often the cause of death in patients with DMD is cardiac failure and arrhythmia.||Trade Name: Eucardic|
Product Name: Eucardic
Product Code: No code
INN or Proposed INN: CARVEDILOL
|Department Of Paediatric Cardiology||NULL||NA||Female: yes|